Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation

Clin Exp Immunol. 1990 Oct;82(1):145-50. doi: 10.1111/j.1365-2249.1990.tb05418.x.

Abstract

Some patients undergoing bone marrow transplantation (BMT) persistently present increased proportions of circulating CD57+ T cells. We analysed the cell surface phenotype in peripheral blood mononuclear cells (PBMC) from 69 allogeneic and 11 autologous BMT recipients. In parallel samples from 49 patients, the proliferative response to T cell mitogens was assessed, either in the presence or absence of exogenous interleukin-2 (IL-2). PBMC samples from long-term allogeneic BMT patients with increased proportions of CD57+ cells displayed significantly (P less than 0.001) lower proliferative responses, compared with samples from patients with normal proportions of CD57+ cells and from healthy subjects. Elimination of the CD57+ population by C'-dependent lysis did not normalize the proliferative response. After positive selection by cell sorting, CD57+ cells responded poorly, but in the presence of IL-2 the proliferation appeared to be similar to that displayed by the CD57- subset and still suboptimal compared with normal controls. These data suggest that the hyporesponsiveness to mitogenic stimuli in the presence of exogenous IL-2 of PBMC from allogeneic BMT recipients cannot be simply attributed either to the putative suppressor activity of CD57+ cells, or to a poor proliferative capacity of this subset. Supporting this notion we report that PBMC from long-term autologous BMT recipients containing high proportions of CD57+ T cells respond normally to T cell mitogens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Differentiation, T-Lymphocyte / immunology*
  • Antigens, Surface / immunology
  • Bone Marrow Transplantation / immunology*
  • CD3 Complex
  • CD57 Antigens
  • Cell Separation
  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Interleukin-2 / pharmacology
  • Lymphocyte Activation* / drug effects
  • Mitogens / pharmacology
  • Receptors, Antigen, T-Cell / immunology*
  • Recombinant Proteins
  • T-Lymphocytes / immunology*

Substances

  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Surface
  • CD3 Complex
  • CD57 Antigens
  • Interleukin-2
  • Mitogens
  • Receptors, Antigen, T-Cell
  • Recombinant Proteins